换一批
换一批Overall survival of super-elderly (85 years or older) advanced non-small cell lung cancer patients with active epidermal growth factor receptor mutations receiving first-line gefitinib therapy: a single-institute retrospective study.
第一作者：
Kosuke,Kashiwabara
第一单位：
Department of Respiratory Medicine, Kumamoto Regional Medical Center, 5-16-10, Honjo, Kumamoto, 860-0811, Japan. kskkswbr@krmc.or.jp.
作者：
主题词
老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);癌, 非小细胞肺(Carcinoma, Non-Small-Cell Lung);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);肺肿瘤(Lung Neoplasms);男(雄)性(Male);突变(Mutation);预后(Prognosis);蛋白激酶抑制剂(Protein Kinase Inhibitors);回顾性研究(Retrospective Studies);存活率(Survival Rate)
DOI
10.1007/s00432-020-03344-1
PMID
32761377
发布时间
2021-01-25
- 浏览7
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
